Market Tracker

09/16 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
5.20 +0.05 / +0.97%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.14 -0.0562 / -1.08%
 
Volume: 31.1K
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close5.15
Today’s open5.10
Day’s range5.05 - 5.24
Volume722,113
Average volume (3 months)1,220,072
Market cap$358.2M
Dividend yield--
Data as of 3:59pm ET, 09/16/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+63.16%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book3.97

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.15+2.13%
DVAXDynavax Technologies...-0.03-2.17%
SUPNSupernus Pharmaceuti...+0.12+1.48%
DRTXDurata Therapeutics ...-0.19-1.36%
Data as of 3:59pm ET, 09/16/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts